New drug combo takes on amlodipine in blood pressure battle for heavier patients
NCT ID NCT07241338
First seen Nov 21, 2025 · Last updated May 17, 2026 · Updated 20 times
Summary
This study tests whether a combination drug (sacubitril/allisartan) works better than the standard medicine amlodipine for lowering blood pressure in overweight or obese adults with high blood pressure. About 104 participants will take one of the two medicines for 8 weeks, and doctors will measure changes in blood pressure and safety. The goal is to find a more effective treatment option for this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.